Wrist Drop in a Patient With Long-Standing Diabetes
Mr. D is a 63-year-old retired mail carrier with a 12-year history of type 2 diabetes (HbA1c 9.2%) and a 5-month history of burning anterior thigh pain, progressive difficulty climbing stairs, and, for 6 weeks, left wrist drop. Examination shows hip flexion 4-/5 bilaterally, shoulder abduction 4/5, left wrist extension 3/5, global areflexia, and diminished pinprick to the mid-shins. Nerve conduction studies show absent sural and superficial peroneal SNAPs; left radial CMAP 1.1 mV with a 62% amplitude drop across the forearm at a site far from any compression point; ulnar and radial SNAPs of 16 and 14 µV; peroneal CMAP 1.0 mV. Needle EMG shows active denervation in left extensor indicis, left deltoid, and tibialis anterior, with chronic changes in right vastus medialis. ESR 42 mm/h, CRP 18 mg/L, CK 210 U/L, normal SPEP, CSF protein 88 mg/dL with 1 white cell. He asks whether this is just his diabetes getting worse.
1. Does this study meet electrophysiologic criteria for CIDP? Build a differential that accounts for both the proximal painful leg syndrome and the upper-limb conduction block.
Read the worked answer
Do the criteria fit? Only partially. Definite CIDP requires robust demyelinating features - conduction block, abnormal temporal dispersion, markedly slowed conduction, prolonged distal latency, or F-wave prolongation - distributed across at least two nerves, with entrapment sites excluded. Here only one clear demyelinating feature is documented: the 62% radial CMAP drop at a non-compression site. Absent sural and superficial peroneal SNAPs in a 12-year diabetic are ordinary axonal length-dependent change and do not count as demyelinating. So this is not definite CIDP on the current data; more nerves must be studied, including F-waves and contralateral limbs.
Differential:
- Diabetic lumbosacral radiculoplexus neuropathy fits the burning thigh pain, asymmetric proximal leg weakness, weight loss pattern, and elevated CSF protein - but it is axonal and does not produce upper-limb conduction block. The wrist drop is the discordant finding.
- Vasculitic neuropathy deserves respect: painful asymmetric deficits, ESR 42, CRP 18. However, vasculitis is axonal; conduction block argues against it as the sole process.
- CIDP with superimposed diabetic polyneuropathy explains both distributions, including the multifocal upper-limb block.
- Paraproteinemic neuropathy: SPEP is normal, but obtain immunofixation and anti-MAG if the pattern becomes distal symmetric and sensory.
- Diabetic cervical radiculoplexus neuropathy is possible for the arm but would not spare the SNAPs as seen here.
Diabetes alone does not cause conduction block outside compression sites; that finding is the hinge of the case.
2. Assuming you treat for immune-mediated neuropathy, what regimen do you choose and why, and what monitoring does he need?
Read the worked answer
First-line: IVIG 2 g/kg divided over 2-5 days, with a plan for reassessment at 3-4 weeks and repeat dosing if he responds. Rationale specific to him:
- Corticosteroids are relatively contraindicated by his HbA1c of 9.2%. High-dose prednisone would predictably worsen glycemia, complicate wound healing, and add to his fall risk; he already has proximal weakness and sensory loss.
- IVIG avoids the metabolic hit and works quickly enough to give an answer within weeks. Check IgA level first if there is any concern for selective deficiency, and review renal function and thrombotic risk (he is a vasculopath by history).
- Plasma exchange is an alternative if IVIG fails or is contraindicated; it is equally first-line in CIDP.
If he responds, plan maintenance IVIG or transition to a steroid-sparing agent such as azathioprine or methotrexate, with the goal of the lowest effective dose and periodic attempts at weaning.
Monitoring:
- Objective strength measures (grip dynamometry, MRC sum score) and disability scales at each visit rather than impressions.
- Renal panel and CBC before each course; glucose remains relevant regardless of therapy.
- If he fails IVIG and steroids, or progresses on treatment, revisit the diagnosis before escalating to cyclophosphamide.
3. Under what circumstances would you proceed to nerve biopsy in this patient, and what would you hope to see?
Read the worked answer
Biopsy is not indicated at this point. He has not yet had an adequate treatment trial, and the study supports an immune-mediated demyelinating process more than an alternative diagnosis.
Reasonable triggers for biopsy:
- Progression despite appropriate immunotherapy - treatment-refractory progression should make you doubt CIDP.
- A vasculitic picture: painful asymmetric multiplex deficits, systemic features, markedly elevated ESR/CRP, or skin, joint, or renal involvement.
- Suspicion of amyloidosis (autonomic failure, carpal tunnel, monoclonal protein) or sarcoidosis.
- Persistent diagnostic uncertainty after extensive nerve conduction testing, especially if the question is vasculitis versus CIDP, because the treatments differ substantially in risk.
What to look for: a combined nerve and muscle biopsy is more sensitive than nerve alone. For vasculitis, look for transmural inflammation of epineurial vessels with fibrinoid necrosis and asymmetric fiber loss between fascicles. For amyloid, Congo red birefringence. For CIDP, onion-bulb formation and segmental demyelination - supportive but not required, and rarely the deciding factor.
Counseling: sural nerve biopsy causes permanent sensory loss over the lateral foot and carries a small risk of painful neuroma or poor wound healing in a diabetic; reserve it for decisions that treatment cannot resolve.